Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Prophase Labs Inc (PRPH)

Prophase Labs Inc (PRPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 18,357
  • Shares Outstanding, K 23,874
  • Annual Sales, $ 44,380 K
  • Annual Income, $ -16,780 K
  • EBIT $ -35 M
  • EBITDA $ -29 M
  • 60-Month Beta -0.10
  • Price/Sales 0.42
  • Price/Cash Flow N/A
  • Price/Book 0.39
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.26
  • Most Recent Earnings $-0.35 on 11/13/24
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 346.11% ( +3.82%)
  • Historical Volatility 194.19%
  • IV Percentile 98%
  • IV Rank 72.30%
  • IV High 467.33% on 11/13/24
  • IV Low 29.66% on 10/18/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 1
  • Volume Avg (30-Day) 48
  • Put/Call OI Ratio 0.07
  • Today's Open Interest 1,149
  • Open Int (30-Day) 908

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.6601 +12.15%
on 11/08/24
2.4000 -69.15%
on 10/28/24
-1.6497 (-69.03%)
since 10/25/24
3-Month
0.6601 +12.15%
on 11/08/24
3.0000 -75.32%
on 09/06/24
-1.9497 (-72.48%)
since 08/23/24
52-Week
0.6601 +12.15%
on 11/08/24
7.4800 -90.10%
on 04/16/24
-3.7497 (-83.51%)
since 11/24/23

Most Recent Stories

More News
ProPhase Labs Announces Financial Results for the Three Months Ended September 30, 2024

PRPH : 0.7452 (-3.08%)
ProPhase Labs Announces Closing of Public Offering of Common Stock

PRPH : 0.7452 (-3.08%)
ProPhase Labs Inc. to Present Third Quarter 2024 Financial Results on November 13, 2024

PRPH : 0.7452 (-3.08%)
ProPhase Labs Announces Pricing of Public Offering of Common Stock

PRPH : 0.7452 (-3.08%)
ProPhase Labs Announces Proposed Public Offering of Common Stock

PRPH : 0.7452 (-3.08%)
ProPhase Labs Launches DNA Complete®: Transforming Direct-to-Consumer Genetic Testing for Health, Wellness, and Enhanced Ancestry

PRPH : 0.7452 (-3.08%)
ProPhase Labs to Present at the 2024 ThinkEquity Conference

PRPH : 0.7452 (-3.08%)
ProPhase Labs Announces Positive Updates on Strategic Initiatives Company Anticipates Multiple Liquidity Events in H1 2025

PRPH : 0.7452 (-3.08%)
ProPhase Dips on Moving Karkus up Ladder

ProPhase Labs, Inc. (NASDAQ: PRPH) fell Tuesday, as the company, a next generation biotech, genomics, ...

PRPH : 0.7452 (-3.08%)
COMSovereign Names Bill White, CFE as New Independent Director and Chair of Audit Committee

/PRNewswire/ -- COMSovereign Holding Corp. (NASDAQ: COMS and COMSP) ("COMSovereign" or the "Company"), a U.S.-based developer of 4G LTE Advanced and 5G...

COMS : 0.0010 (unch)
PRPH : 0.7452 (-3.08%)

Business Summary

ProPhase Labs, Inc., formerly known as The Quigley Corporation, is a manufacturer, marketer and distributor of a diversified range of homeopathic and health products that are offered to the general public. The Company's mission is to develop and market natural health care pharmaceuticals and nutriceuticals...

See More

Key Turning Points

3rd Resistance Point 0.8455
2nd Resistance Point 0.8228
1st Resistance Point 0.7958
Last Price 0.7452
1st Support Level 0.7461
2nd Support Level 0.7234
3rd Support Level 0.6964

See More

52-Week High 7.4800
Fibonacci 61.8% 4.8748
Fibonacci 50% 4.0701
Fibonacci 38.2% 3.2653
Last Price 0.7452
52-Week Low 0.6601

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar